News
29th January 2021
Study into COVID-19 persistence in the gut is recruiting participants in Norwich
The Quadram Institute on the Norwich Research Park, working with the Norfolk and Norwich University Hospital, is looking to recruit participants who have tested positive for COVID-19 within the last 2 weeks, to help understand more about the virus. The coronavirus disease (COVID-19), caused...
View11th January 2021
New flour brings health power of pulses to our daily bread
Researchers from the Quadram Institute and King’s College London have shown that replacing wheat flour with a new ingredient derived from chickpeas improved the glycaemic response of people eating white bread. The ingredient uses specially-developed milling and drying processes that preserves cellular structure, making...
View11th January 2021
Researchers provide new insights into how antibiotic resistance develops
Researchers at the Quadram Institute on the Norwich Research park have shown how the development of antibiotic resistance by bacteria can have ‘side-effects’ for them including affecting their ability to cause disease. Antibiotic resistance remains one of the greatest challenges to global health with...
View6th December 2016
New study unravels critical genes to understand human diseases and support drug discovery
A network analysis of proteins that are most important in responding to environmental signals highlights potential targets for drugs and provides better information on the genetic basis of diseases. Throughout evolutionary history, there have been genetic elements that have duplicated – giving rise to...
View6th December 2016
Scientists spend a week at Westminster
Two scientists from Norwich Research Park have taken part in a Royal Society scheme to bring the worlds of politics and science closer together. The initiative, run by the Royal Society – the UK’s national academy of science – with support from the Government...
View29th November 2016
Combining the power of 27 data resources, Omnipath helps researchers see biological signalling pathways with unprecedented accuracy. Developed by researchers in the UK and Germany and published in Nature Methods, OmniPath offers a comprehensive, unified collection of literature-curated signalling pathways based on an...
View4th November 2016
Diversity in C. botulinum germination
A new study has filled a gap in our knowledge of germination of Clostridium botulinum, one of the most dangerous causes of food poisoning. C. botulinum bacteria produce a highly potent neurotoxin that if present in the body causes botulism, which often leads to...
View26th October 2016
Landmark alliance launched to support the growth of the UK bioeconomy
The Norwich Research Park Biorefinery Centre has joined a new alliance of similar established R&D centres, called BioPilotsUK. This alliance will seek to position Britain as a global leader in biorefining technology development and bio-based product manufacture – two key elements of the bioeconomy....
View18th October 2016
Norfolk hospital and science partnership cure patients of debilitating gut infection
A treatment programme for Clostridium difficile (C.diff) is being announced during International Infection Prevention Awareness Week 17-21 October. In the last year, the lives of 20 patients diagnosed with C. diff, a bacterium that infects the gut, have been transformed by the Norfolk and...
View17th October 2016
IFR helps to combat serious gut infections with FMT
A collaboration between the NNUH and IFR has been crucial to the success of the Intestinal Microbiota Transfer (IMT), also referred to as Faecal Microbiota Transplants (FMT), to combat Clostridium difficile infection, but this also extends beyond, as we are interested in learning more...
View